Visiopharm raised €13M in a funding round in Aug 2018. The company is based in Denmark. Investors in the round: ATP, Vækstfonden. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
